Search Results For ''

  • FDA relaxes clinical trial guidelines, opens U.S opportunity to Visioneering

    Medtech developer Visioneering Technologies (ASX: VTI) may soon have its NaturalVue Multifocal (NVMF) contact lenses re-classified by the FDA which has just approved the first contact lenses which slow the progression of nearsightedness.  The FDA approval was given to CooperVision’s MiSight® 1 day contact lens which slows the progression of myopia specifically in children. The

    Read More
    Public
  • Small Cap Watch – Specialty Metals International (SEI)

    Small miners, like most small-cap stocks, trade based on the announcement of milestones; Discovery of promising exploration sites, proving of reserves, and completing feasibility studies. However, usually the biggest jump in a small miner’s share price is when they announce the start of resource production. This is a milestone that many small miners don’t reach,

    Read More
    Public
  • ServTech launches virtual reality tech in Canada, capitalising on building activity

    With Toronto, currently in the midst of a mini housing boom which has seen rises in house prices and an influx of commercial development, Australian tech company ServTech Global (ASX: SVT) is set to launch their virtual reality (VR) and augmented reality (AR) software in Canada. The expansion comes via a software distribution agreement with

    Read More
    Public
  • XJO set to open flat after another US record

    The XJO has been toying with potential resistance at the 6,750 – 6,775 level, after breaking the level on Friday. If the XJO can break this resistance convincingly, we should eventually see the XJO continue higher towards the all-time high level at 6,875, which should be the next resistance. If we fall through 6,750, the

    Read More
    Public
  • HeraMED shares surge 51% following FDA approval for fetal heart monitor

    Medtech company HeraMED (ASX: HMD) has seen a major spike in investor confidence after securing clearance from the US Food and Drug Administration (FDA) for HeraBEAT US – their fetal ultrasonic heart monitor.  Intended to detect, display and replay heart beats from as early as 12 weeks into pregnancy, the handheld device was developed in

    Read More
    Public
  • Medical cannabis adoption trend continuing in UK after Althea Group secures key licence

    Australian-based Medical Cannabis producer and supplier, Althea Group (ASX: AGH), have announced this morning that their Bristol-based medical clinic site has secured a licence from a UK independent health and social care regulator. The news suggests that medical cannabis is becoming increasingly accepted in the UK as a treatment option for chronic health conditions.  Wholly

    Read More
    Public